Randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line chemotherapy in advanced non-small cell lung cancer. Background: PFS based endpoints are ...
Explainable Machine Learning to Predict Treatment Response in Advanced Non–Small Cell Lung Cancer We conducted a retrospective study using claims data from three Japanese institutions, including two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results